GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » YoY EPS Growth

Pharmaresearch Bio Co (XKRX:217950) YoY EPS Growth : 213.01% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Pharmaresearch Bio Co's YoY EPS Growth for the quarter that ended in Dec. 2024 was 213.01%.

Pharmaresearch Bio Co's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was ₩1,781.00.

Pharmaresearch Bio Co YoY EPS Growth Historical Data

The historical data trend for Pharmaresearch Bio Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co YoY EPS Growth Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
Get a 7-Day Free Trial 102.38 11,320.00 221.02 -68.96 213.01

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth Get a 7-Day Free Trial 102.38 11,320.00 221.02 -68.96 213.01

Pharmaresearch Bio Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Pharmaresearch Bio Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(1781-569)/ | 569 |
=213.01 %

Pharmaresearch Bio Co's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 ) |
=(1781-569)/ | 569 |
=213.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaresearch Bio Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » YoY EPS Growth
Comparable Companies
XKRX:353810 XKRX:086890 XKRX:083790 XKRX:060590 XKRX:234690 XKRX:203400 XKRX:002630 XKRX:321550 XKRX:376270 XKRX:299660 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Website
http://www.pr-bio.co.kr
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines